Origin Therapeutics 2021 Corporate Presentation – Psychedelic Investment

Origin Therapeutics is an actively-managed investment issuer providing diversified exposure to the psychedelic industry. The company offers retail investors access to a curated portfolio of private psychedelic companies with significant deal flow and professional investment selection across a $100 billion market opportunity.